J. Lacrampe

Preparation of piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication

K. Andries, J. Guillemont, Jean-François Bonfanti, 2005 .

Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship.

K. Andries, P. Timmerman, E. Arnoult, 2007, Journal of medicinal chemistry.

Identification of R146225 as a novel, orally active inhibitor of interleukin-5 biosynthesis.

F. Aerts, F. Deroose, J. Lacrampe, 2000, The Journal of pharmacology and experimental therapeutics.

Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus.

M. Moeremans, K. Andries, P. Wyde, 2003, Antiviral Research.

Synthesis and biological evaluation of 1,2,4-triazinylphenylalkylthiazolecarboxylic acid esters as cytokine-inhibiting antedrugs with strong bronchodilating effects in an animal model of asthma.

L. Dillen, F. Deroose, J. Lacrampe, 2005, Journal of medicinal chemistry.

Analogues de 3-phenyle de toxoflavine en tant qu'inhibiteurs de kinase

P. Buijnsters, C. Ho, J. Lacrampe, 2003 .

Synthesis of bridged azabicyclic ketones. Solvolysis of enol ether ethylene ketal N-cholramines in acidic medium

B. Waegell, G. Esposito, R. Furstoss, 1976 .

JNJ-26854165 - a novel hdm2 antagonist in clinical development showing broad-spectrum preclinical antitumor activity against solid malignancies

C. Blattner, M. Janicot, P. Verhasselt, 2008 .